What causes low hemoglobin with a high platelet count and what is the appropriate work‑up and treatment?

Low Hemoglobin with High Platelet Count: Iron Deficiency Anemia

The most common cause of decreased hemoglobin with increased platelets is iron deficiency anemia (IDA), which triggers reactive thrombocytosis in approximately 8% of cases, and treatment with iron supplementation resolves the thrombocytosis within 2-6 weeks 1.

Pathophysiology and Clinical Significance

Iron deficiency anemia causes reactive thrombocytosis through compensatory bone marrow stimulation. The elevated platelet count is secondary thrombocytosis and typically does not increase thrombotic risk unless additional risk factors are present 2. However, patients with IDA-induced thrombocytosis demonstrate more severe anemia, lower ferritin levels, and more advanced iron deficiency compared to IDA patients without thrombocytosis 1.

Key Distinguishing Features

When evaluating this pattern, you should specifically look for:

• Ferritin levels: Use a cutoff of 45 mg/dL for diagnosing iron deficiency in anemic patients 3
• Transferrin saturation, soluble transferrin receptor, or reticulocyte hemoglobin: Particularly important if inflammatory conditions are present (ferritin may be 45-100 mg/dL despite iron deficiency) 3
• Mean corpuscular volume (MCV): Typically low in IDA
• Platelet count severity: Thrombocytosis >450 × 10⁹/L occurs in 8.1% of IDA patients 1

Diagnostic Work-Up Algorithm

1. Confirm true thrombocytopenia by repeating platelet count in heparin or sodium citrate tube to exclude pseudothrombocytopenia 4

2. Assess iron studies:

   • Ferritin <45 mg/dL confirms iron deficiency 3
   • If ferritin 45-100 mg/dL with inflammation, obtain confirmatory testing 3
   • Check transferrin saturation and total iron-binding capacity 1

3. Identify the source of iron loss 3:

   • Dietary iron intake assessment
   • Menstrual blood loss history in premenopausal women
   • Gastrointestinal evaluation for malabsorption or bleeding (H. pylori, celiac disease, inflammatory bowel disease, occult GI bleeding)
   • Consider upper endoscopy and colonoscopy for unexplained IDA

4. Exclude primary thrombocytosis: Secondary thrombocytosis from IDA has lower platelet counts than primary myeloproliferative disorders and lacks arterial thrombotic complications 2

Treatment Approach

Iron replacement is the definitive treatment and will normalize both hemoglobin and platelet counts 1.

Iron Supplementation Strategy

Oral iron first-line 3:

• Ferrous sulfate, ferrous fumarate, or ferrous gluconate (least expensive options)
• Take on empty stomach for optimal absorption, or with meals if better tolerated
• Co-administer with 500 mg vitamin C to enhance absorption
• Taking with meat protein improves absorption 3

Intravenous iron indications 3:

• Severe iron deficiency
• Oral iron intolerance (nausea, abdominal pain, constipation)
• Conditions with poor oral absorption (celiac disease, inflammatory bowel disease)
• Failure to improve iron stores with oral supplementation

Thrombocytosis Management

Monitor platelet counts during iron replacement 1:

• 50% of patients with thrombocytosis normalize platelets within 2 weeks
• All patients resolve thrombocytosis within 6 weeks of iron treatment
• Increase follow-up frequency in patients with thrombocytosis >450 × 10⁹/L to monitor for thrombotic events 1

No antiplatelet therapy needed unless additional thrombotic risk factors are present, as secondary thrombocytosis from IDA does not independently increase thrombotic risk 2.

Critical Pitfalls

• Do not assume thrombocytosis is benign: While IDA-induced thrombocytosis rarely causes thrombosis alone, case reports document thrombotic complications 1. Patients with persistent thrombocytosis despite iron treatment require evaluation for concomitant clonal myeloproliferative disorders 1.

• Inflammatory conditions mask iron deficiency: Ferritin can be falsely elevated (45-100 mg/dL) in inflammation while true iron deficiency exists 3. Always obtain confirmatory testing in these scenarios.

• Celiac disease requires gluten-free diet: Iron supplementation alone is insufficient; ensure adherence to gluten-free diet to improve iron absorption 3.

• Consider multidisciplinary management: Complex cases benefit from gastroenterology (for source identification), hematology (for complex anemia or IV iron access), and nutrition consultation 3.